Charles Marcus MBBS, Presenter: Nothing to Disclose

Alexander Antoniou MD, MA, Abstract Co-Author: Nothing to Disclose

Esther Mena, Abstract Co-Author: Nothing to Disclose

Rathan M. Subramaniam MD, PhD, Abstract Co-Author: Speakers Bureau, Eli Lilly and Company

1. Discuss a systematic approach to examining and reporting cervical lymph nodes in patients with head and neck cancer. 2. Discuss the anatomical and metabolic phenotypic adverse outcome features of nodal metastasis. 3. Discuss the value and clinical context of FDG and FLT PET/CT in the evaluation of nodal metastases in head and neck cancer. 4. Discuss the pitfalls of radiation induced inflammation, low FDG avid nodal metastasis, and necrotic nodal metastasis.  

• Describe a systematic approach to identify and categorize abnormal cervical lymph nodes. • Discuss the anatomical and metabolic phenotypic adverse outcome features of nodal metastasis. • Pitfalls in routine anatomic imaging of cervical lymph nodes. • Advantages of PET combined with contrast-enhanced CT over conventional imaging. • Impact of PET/CT in the staging, therapy assessment, follow-up and prognosis of patients with head and neck cancer. • Role of different radiotracers, including FLT, in the evaluation of neck nodes. • Pitfalls of PET/CT in the evaluation of cervical lymph nodes.  

http://abstract.rsna.org/uploads/2014/14018045/14018045_l8q5.pdf

Marcus, C, Antoniou, A, Mena, E, Subramaniam, R, Value of FDG and FLT PET/CT in the Evaluation of Cervical Lymph Nodes in Head and Neck Cancer.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14018045.html